The thyroid plays a large role in your overall health. While there is no known way to prevent thyroid cancer, some things that may help to maintain thyroid health are the lifestyle choices you make. Rutgers Cancer Institute of New Jersey experts share more.
Despite a cancer diagnosis and/or cancer treatment, there are smokers who continue with the difficult addiction. As the state’s only National Cancer Institute- designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey now offers a new program, part of the National Cancer Institute’s Moonshot Program, designed to integrate tobacco treatment into the patient-care workflow, to provide state-of-the-art tobacco treatment and cessation support to all patients at no cost.
Cervical cancer is the only gynecologic cancer that can be prevented—and there are numerous tools to promote prevention including vaccines and tested strategies. James K. Aikins, Jr., MD, FACOG, FACS, chief of Gynecologic Oncology at Rutgers Cancer Institute of New Jersey and associate professor of Obstetrics, Gynecology and Reproductive Sciences at Rutgers Robert Wood Johnson Medical School shares more information about cervical cancer prevention through HPV vaccination, routine PAP tests and lifestyle choices.
Researchers from Rutgers Cancer Institute of New Jersey, the state’s only NCI-designated Comprehensive Cancer Center, examined the effects of SIRT1, an enzyme located primarily in the cell nucleus that contributes to cellular regulation on the transformation of T-cells.
Research underway at Rutgers Cancer Institute of New Jersey will contribute to the development of new cancer treatments that are based on the administration of cancer-fighting immune cells to patients.
Investigators at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS) explored how Artificial Intelligence/Machine Learning will complement existing approaches focused on genome-protein sequence information, including identifying mutations in human tumors published online December 2 in The New England Journal of Medicine.
Expert research at Rutgers Cancer Institute of New Jersey focuses on psychosocial aspects of pediatric, adolescent, and young adult cancer survivorship, including survivorship care and health promotion for survivors. Katie Devine, PhD, MPH, is section chief of Pediatric Population Science, Outcomes, and Disparities Research in the Division of Pediatric Hematology/Oncology at Rutgers Cancer Institute shares more.
Fatigue, or constant feeling of tiredness, is very common in people with cancer and can affect a patient physically, emotionally and mentally. Andrew Kass, RN, MSN, AGNP-C, AOCNP, advanced practice nurse at Rutgers Cancer Institute of New Jersey, the state’s only NCI-designated Comprehensive Cancer Center together with RWJBarnabas Health, shares more about the signs and symptoms of cancer related fatigue, encourages patients to work with their cancer care team and provides tips on how to better manage fatigue.
n a recent paper, investigators from Rutgers University including Rutgers Cancer Institute of New Jersey, Rutgers School of Public Health and Rutgers Robert Wood Johnson Medical School recently addressed the progress of behavioral and preventative medicine and the mission and vision of cancer prevention and control research in the future.
The hustle and bustle of the #holiday season often brings stress. Rutgers Cancer Institute social workers Gabrielle Alvarez and Samantha Campanella share some practical tips to minimize stress when coping with cancer during this holiday season.
Germline testing checks an eligible person's DNA for genetic inherited mutations that could potentially increase the risk of developing cancers or other health problems. Rutgers Cancer Institute experts share about their work on germline testing published online in JCO Precision Oncology.
Russell Langan, MD, surgical oncologist at Rutgers Cancer Institute of New Jersey, chief of Surgical Oncology and Hepatopancreatobiliary Surgery at Saint Barnabas Medical Center (SBMC) and assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more information on monitoring pancreatic cysts and pancreatic cancer.
Compared with all other racial and ethnic groups in the United States, Black people are disproportionally more affected by lung cancer. Sharon R. Pine, PhD, a resident member of Rutgers Cancer Institute of New Jersey, associate professor of Pharmacology and Medicine at Rutgers Robert Wood Johnson Medical School and member of the Cancer Health Equity Center of Excellence e, discusses the barriers that Black people face, the research being done on racial health disparities and how action can be taken now.
Being a caregiver can be challenging for all but, especially for a person with cancer. Emotional support help with medical care and serving as the communicator between the patient and health care team are just a few of these challenges. Arlene D. Cruz, RN, BSN, OCN, nurse clinician at Rutgers Cancer Institute of New Jersey, helps to examine the issues facing caregivers of patients with cancer and shares how oncology nurses and caregivers can work together and support each other throughout the cancer journey.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have partnered with Horizon Blue Cross Blue Shield of New Jersey to launch a collaborative pilot program which provides oncology care to eligible patients in the comfort of their own home - the first of its kind in the state.
Findings from a recent population based cohort study published online in JAMA Oncology show that Black women diagnosed with breast cancer who also have central obesity, which means excess body fat in the abdominal area, were more likely to die from breast cancer or any other cause than similar women who didn’t have central obesity.
The outlook for patients diagnosed with breast cancer has been changing for the better over time thanks to surgical advances, clinical trials & a more personalized treatment approach. Dr. Lindsay Potdevin, surgical oncologist at Rutgers Cancer Institute of New Jersey, shares how these advances are improving the lives of patients.
Bruce Haffty, MD, MS, chair of Radiation Oncology and associate vice chancellor for Cancer Programs at Rutgers Cancer Institute of New Jersey, shares insight on proton therapy, a unique type of radiation treatment, for breast cancer.
Mammograms are the most effective breast cancer screening tool. Rutgers Cancer Institute's Dr. Deborah Toppmeyer addresses the importance of mammograms, impact of screening due to COVID-19 & how we are moving forward.
Research Results from Rutgers Cancer Institute of New Jersey Presented at American Urological Association Annual Meeting
It's thyroid cancer awareness month. Amanda M. Laird, MD, FACS, chief of endocrine surgery at Rutgers Cancer Institute of New Jersey and associate professor of surgery at Rutgers Robert Wood Johnson Medical School, shares five facts about thyroid cancer everyone should know.
Kevin David, MD the director of the lymphoma program and a hematologist/oncologist at Rutgers Cancer Institute of New Jersey shares information about leukemias and lymphomas for blood cancer awareness month.
Over the last decade, advancements have been made in the diagnosis and treatment of prostate cancer that are saving more lives. Tina Mayer, MD, a medical oncologist in the Prostate Cancer Program at Rutgers Cancer Institute of New Jersey shares some insight.
Tina Mayer, MD, medical oncologist in the Prostate Cancer Program at Rutgers Cancer Institute of New Jersey and an associate professor of medicine at Rutgers Robert Wood Johnson Medical School, shares information about prostate health.
September is Gynecologic Cancer Awareness Month. Rutgers Cancer institute of New Jersey Gynecologic Oncology Chief Dr. James Aikins reminds women about the types of gynecologic cancers and their warning signs
Karen Long-Traynor, PhD, clinical psychologist in the Pediatric Hematology/Oncology Program at Rutgers Cancer Institute of New Jersey, addresses the psychological effects of childhood cancer on children and their families.
Expanding its multidisciplinary teams of highly specialized experts uniquely focused on the management of head and neck cancers and cancer of the lung, pleura and mediastinum, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have welcomed Missak Haigentz, Jr., MD, as chief of Thoracic and Head and Neck Medical Oncology and clinical director for Oncology Integration.
Researchers from Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, recently discovered a mechanism to explain what drives the formation of mucinous colorectal adenocarcinoma (MAC), a rare subtype of colorectal cancer.
The COVID-19 pandemic has brought a time period of grief in many forms, even grief unrelated to the loss of life – some caused by the need for isolation measures to slow the spread of the virus.
Carolyn Hayes, PhD, RN, NEA-BC, chief nursing officer for Oncology Services at RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, has been selected by the American Academy of Nursing (AAN) as a 2021 Fellow. Induction into the Academy is a significant milestone in a nurse leader’s career in which their accomplishments are honored by their colleagues within and outside the profession.
Peter Cole, MD, chief of Pediatric Hematology/Oncology at Rutgers Cancer Institute of New Jersey shares healthy habits and reminders that may help ease the transition back into the classroom as students begin to adjust to full-time school after months of online or hybrid learning.
For cancer patients undergoing treatments, palliative care can provide excellent pain and symptom management that can help them feel better. Palliative care experts at Rutgers Cancer Institute of New Jersey answer common questions about how palliative care can enhance quality of life for patients to highlight palliative care and cancer pain awareness month.
Rutgers Cancer Institute of New Jersey resident researcher was recently awarded a 2021 AACR-Bayer Innovation and Discovery Grant (21-80-44-HERR) from the American Association for Cancer Research (AACR) to further explore a novel mitochondrial uncoupling drug in the treatment of leukemia and a potential therapeutic strategy against T-ALL.
Rutgers Cancer Institute of New Jersey expert shares how to check for skin cancer.
Governor Phil Murphy recently signed the fiscal year 2022 state budget, which included a $10 million appropriation to support pediatric cancer research. This legislation, which was sponsored by Senate President Stephen M. Sweeney and Senator Anthony M. Bucco, will support the establishment of the Pediatric Cancer Center at Rutgers Cancer Institute of New Jersey, which in partnership with RWJBarnabas Health, is a leader in pediatric cancer research and care.
Dr. Salma Jabbour has been named a Fellow of the American Society of Radiation Oncology (FASTRO). This distinction honors individuals who have made significant contributions to the society and to the field of radiation oncology through research, education, patient care and service to the field.
Therapies such as chemotherapy, radiotherapy, immunotherapy and other novel targeted treatments that are used to combat many cancers have the potential to contribute to cardiac toxicity. Rutgers Cancer Institute expert sheds light on the field of Cardo-Oncology, which focuses on the prevention and treatment of cardiac-related issues in cancer patients.
Rutgers Cancer Institute of New Jersey Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences, has been named by the business journal NJBIZ as a 2021 Healthcare Hero in the healthcare professional category.
Ultraviolet rays from the sun can be harmful and damaging to our skin. While skin cancer can be detrimental, it is also highly preventable. Skin cancer expert from Rutgers Cancer Institute answers common questions to protect yourself from the sun.
Researchers at Rutgers Cancer Institute of New Jersey, Rutgers New Jersey Medical School (NJMS) and the Center for Theoretical Biological Physics (CTBP) at Rice University in Houston, Texas, have demonstrated that a technology with favorable biological attributes known as phage display could be a viable platform for the development of new vaccines to protect against COVID-19.
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, in partnership with the New Brunswick Development Corporation (DEVCO), broke ground on the state’s first freestanding cancer hospital.
A diverse, global team of scientists led by a Rutgers Cancer Institute of New Jersey leader has been selected for the final stages of Cancer Grand Challenges – with a chance of securing a share of $111 million in funding to take on one of cancer’s toughest problems.
A person with cancer who identifies as lesbian, gay, bisexual, transgender or non-binary may have unique concerns about communicating with their cancer care team, navigating the healthcare system and coping with their diagnosis. An expert from Rutgers Cancer Institute calls attention to the healthcare challenges and barriers faced by this community during Pride Month and explains how health care professionals are becoming better allies.
Researchers at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS) recently discovered a phage display-based approach to halt tumor growth that could be used to treat triple-negative breast cancer – considered the most aggressive type of breast cancer. The findings were published online in the scientific journal eLife.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right